Atlantic Bone Screen also work on bone diseases from tumoral origin and can evaluate the efficacy and cytotoxicity of compounds on tumoral cell lines:
- HOS1544 (human osteosarcoma)
- MG63 (human osteosarcoma)
- SaOS2 (human osteosarcoma)
- U2OS (human osteosarcoma)
- OSRGa (rat osteosarcoma)
- POS-1 (mouse osteosarcoma)
- BCSCH03 (human chondrosarcoma)
- A-673 (human Ewing sarcoma)
- TC-71 (human Ewing sarcoma)
- SK-ES-1 (human Ewing sarcoma)
- RD-ES (human Ewing sarcoma)
- CADO-ES (human Ewing sarcoma)
- MDA-MB-231 (human mammary carcinoma)
Atlantic Bone Screen also uses these cell lines for in-vivo evaluation of compound.
